Notable Labs (NASDAQ:NTBL) Shares Down 27.7% – Should You Sell?

Notable Labs, Ltd. (NASDAQ:NTBL) shares were down 27.7% during trading on Wednesday . The stock traded as low as $0.24 and last traded at $0.25. Approximately 2,111,200 shares traded hands during mid-day trading, an increase of 108% from the average daily volume of 1,012,707 shares. The stock had previously closed at $0.34.

Wall Street Analysts Forecast Growth

Separately, JMP Securities lowered shares of Notable Labs from an “outperform” rating to a “market perform” rating in a report on Friday, September 20th.

Notable Labs Stock Down 27.7 %

The company has a quick ratio of 2.77, a current ratio of 2.77 and a debt-to-equity ratio of 0.03. The company’s fifty day simple moving average is $0.39 and its 200 day simple moving average is $0.63.

Notable Labs (NASDAQ:NTBL) last released its earnings results on Wednesday, August 14th. The company reported ($0.55) earnings per share (EPS) for the quarter. Sell-side analysts predict that Notable Labs, Ltd. will post -0.75 EPS for the current fiscal year.

Notable Labs Company Profile

Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment.